- Home
- ADVM vs QSI Comparison
ADVM vs QSI Comparison
Compare ADVM & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- QSI
- Stock Information
- Founded
- ADVM 2006
- QSI 2013
- Country
- ADVM United States
- QSI United States
- Employees
- ADVM N/A
- QSI N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- ADVM Health Care
- QSI Health Care
- Exchange
- ADVM Nasdaq
- QSI Nasdaq
- Market Cap
- ADVM 47.4M
- QSI 219.8M
- IPO Year
- ADVM 2014
- QSI N/A
- Fundamental
- Price
- ADVM $2.39
- QSI $2.12
- Analyst Decision
- ADVM Strong Buy
- QSI Strong Buy
- Analyst Count
- ADVM 5
- QSI 3
- Target Price
- ADVM $23.80
- QSI $2.38
- AVG Volume (30 Days)
- ADVM 338.5K
- QSI 8.4M
- Earning Date
- ADVM 08-11-2025
- QSI 08-06-2025
- Dividend Yield
- ADVM N/A
- QSI N/A
- EPS Growth
- ADVM N/A
- QSI N/A
- EPS
- ADVM N/A
- QSI N/A
- Revenue
- ADVM $1,000,000.00
- QSI $3,443,000.00
- Revenue This Year
- ADVM N/A
- QSI $77.57
- Revenue Next Year
- ADVM $18.82
- QSI $251.34
- P/E Ratio
- ADVM N/A
- QSI N/A
- Revenue Growth
- ADVM N/A
- QSI 167.94
- 52 Week Low
- ADVM $1.78
- QSI $0.61
- 52 Week High
- ADVM $10.14
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- ADVM 44.75
- QSI 62.22
- Support Level
- ADVM $2.11
- QSI $1.87
- Resistance Level
- ADVM $2.60
- QSI $2.14
- Average True Range (ATR)
- ADVM 0.22
- QSI 0.13
- MACD
- ADVM -0.00
- QSI 0.01
- Stochastic Oscillator
- ADVM 36.39
- QSI 84.75
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.